i-GENTIC: Quantum-era governance to reshape fintech & health

Financial services, healthcare and life sciences organisations are expected to begin building formal controls around quantum-era risks in 2026.

According to Zahra Timsah, CEO of Houston-based AI firm i-GENTIC AI, companies in highly regulated sectors have shifted from debating the timeline for quantum computing to planning for how it might affect real-world decisions and data.

"If nature is quantum, then computation eventually becomes quantum," she said. "But the part everyone forgets is this: if quantum touches data, makes decisions, or affects outcomes, we need to govern it. We can't expect technology that disobeys classical physics to magically obey business rules."

Quantum computing research has advanced in recent years, yet many systems remain fragile and difficult to operate. The technology continues to sit between scientific experiment and a speculative future tool for large-scale problem-solving.

Timsah said firms in sectors that carry systemic or safety-critical risk are starting to act on the assumption that quantum systems will, at some stage, interact with operational data and models.

"The smartest players are preparing early," she said. "Not out of hype, but because unpredictability is the real risk. Quantum computers don't have to break the world to cause problems. All they have to do is behave inconsistently."

Fintech guardrails

In financial services, Timsah expects the first wave of quantum-related work to focus on consistency in models that support risk, fraud and credit decisions. These models currently rely on deterministic behaviour and traceable decision paths.

She predicts that "deterministic governance agents" will sit between quantum systems and production workflows. These agents would monitor outputs and enforce business rules before any decision reaches front-line systems.

Timsah said banks are likely to test quantum-based risk simulations internally and without major public disclosure. She expects firms to avoid discussing topics that might raise concerns about the stability of payment networks or cryptographic systems.

Healthcare security

In healthcare, Timsah expects security teams to focus on post-quantum cryptography before the large-scale deployment of quantum computers. Many organisations already face the risk that attackers could store encrypted data now and decrypt it in the future.

"Healthcare will move early on post-quantum cryptography, not because quantum computers exist in the wild, but because healthcare can't afford to be the last sector to modernize security."

She noted that medical records often contain lifelong histories and cannot easily be replaced once leaked.

Timsah expects healthcare providers and regulators to use software agents that verify encryption schemes, identity controls and data handling processes on an ongoing basis. These agents would compare practice against emerging quantum-safe standards and flag deviations.

Drug discovery checks

In life sciences, Timsah expects early use of quantum-inspired and quantum-based simulations in drug discovery, molecular modelling and protein folding research. These applications sit at the intersection of experimental science and regulatory oversight.

She said the sensitivity of quantum systems creates challenges for reproducibility. Small environmental changes during a computation can lead to different outcomes.

"In drug discovery, inconsistency isn't a 'bug,'" Timsah said. "It's a regulatory red flag. If quantum simulations generate insights that aren't reproducible, they're not admissible, no matter how brilliant."

For laboratories that experiment with quantum methods, she expects governance systems that track simulation behaviour in fine detail. These systems would log quantum state transitions and record configuration data.

She said to expect governance systems that validate simulation outputs, log every quantum state transition, and compare quantum-derived predictions against classical baselines.